NORTHWEST BIOTH NEW | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (3)

View All

Latest Articles

About This Stock More About This Stock
Biotech Stocks: The Sector's Most Comprehensive Immunotherapy Platforms
Article By: BioMedReports
Friday, November 7, 2014 4:58 AM EDT
The National Cancer Institute (NCI) spends upwards of $4.9 billion each year on cancer research.
In this article: INO, NWBO, TPIV, DNDN, GALE
Read
Northwest Biotherapeutics: A Variety Of Possibilities With The Future Of Immunotherapy Treatments
Article By: Terry Chrisomalis
Tuesday, October 21, 2014 10:18 AM EDT
Northwest Biotherapeutic's recent news suggests a great buying opportunity.
In this article: NWBO
Read
Healthcare Review: CPRX, CANF, ACST, NWBO, ACT
Article By: BioMedReports
Wednesday, October 1, 2014 3:35 AM EDT
The Dow Jones Industrial Average rose 37 points, or 0.2%, to 17108. The S&P 500 added four points, or 0.2%, to 1982, and the Nasdaq Composite Index rose six points, or 0.1%, to 4512.
In this article: NWBO, ACST, CPRX, ACT, CANF
Read
All Posts

Latest Tweets for $NWBO

No tweets yet!

PARTNER HEADLINES